Innovative Immunmodulation zur Bekämpfung von Stoffwechselerkrankungen

• Literatur

• 1 Serr I, Fürst RW, Achenbach P. et al. Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice. Nat Commun 2016; 7: 10991
• 2 Serr I, Fürst RW, Ott VB. et al. miRNA92a targets KLF2 and PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. PNAS 2016; 113: E6659-E6668
• 3 Serr I, Scherm MG, Zahm AM. et al. A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes. Sci Transl Med 2018; 10: eaag1782
• 4 Scherm MG, Serr I, Zahm AM. et al. miRNA142–3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes. Nature Communications 2019; 10: 5697
• 5 Becker M, Dirschl SM, Scherm MG. et al. Niche-specific control of tissue function by regulatory T cells – Current challenges and perspectives for targeting metabolic disease. Cell Metab 2024; 36: 229-239
• 6 Kälin S, Becker M, Ott VB. et al. A Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue Function. Cell Metab 2017; 26: 475-492e477
• 7 Becker M, Serr I, Salb VK. et al. Short-term cold exposure supports human Treg induction in vivo. Mol Metab 2019; 28: 73-82
• 8 Becker M, Joseph SS, Garcia-Carrizo F. et al. Regulatory T cells require IL-6 receptor alpha signaling to control skeletal muscle function and regeneration. Cell Metab 2023; 35: 1736-1751.e7
• 9 Becker M, Kälin S, Neubig A. et al. Regulatory T-cells in the hypothalamus control immune activation and improve metabolic impairments upon high-calorie environments. Nat Commun 2025; 16: 2744